Bausch Health Companies | Des Atouts



Assets Changement Date
Amgen USD 87.9B 1.47B 2025-06
ANI Pharmaceuticals USD 1.34B 50.57M 2025-06
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 27.27B 845M 2025-06
Biogen USD 28.33B 297.1M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Danaher USD 81.62B 2.5B 2025-06
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 100.92B 11.53B 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
Novo Nordisk 482.15B 7.01B 2025-06
Pacira USD 1.54B 49.41M 2025-06
Perrigo USD 10.09B 334.3M 2025-06
Prestige Brands USD 3.43B 29.41M 2025-06
Supernus Pharmaceuticals USD 1.38B 35.11M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06
Zoetis USD 14.48B 381M 2025-06


Bausch Health Companies Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.